Spelling suggestions: "subject:"sulfotransferase"" "subject:"aminotransferases""
21 |
Characterisation of the SULT1A1 polymorphism in a South African Tswana population group / y Hlengiwe P. Mbongwa.Mbongwa, Hlengiwe Prosperity January 2010 (has links)
This dissertation brings to the fore the “Characterization of the SULT1A1 polymorphism in a
South Africa Tswana population group.” The primary experimental group studied came from
South African homogeneous Tswana individuals who participated voluntarily in an ongoing
large-scale epidemiological Prospective Urban and Rural Epidemiological (PURE) study the
North-West University (Potchefstroom Campus) participates in, as one of the 16 low- middleand
high-income countries across the world.
The primary aspect investigated was the comprehensive profile of the single nucleotide
polymorphism (SNP) and copy number variation (CNP) of the SULT1A1 gene. Using the PCRbased
RFLP method, SULT1A1 genotypes, and allele frequency distributions in an
experimental group of 1 867 individuals were determined. According to the literature this is by
far the largest and most homogeneous group from which such information has been acquired to
date. The SULT1A1*1, SULT1A1*1/*2 and SULT1A1*2 genotypes were found to be present at
a percentage of 43.76, 47.12 and 9.11 respectively. In comparison to similar studies in other
population groups, results from this study indicate that there are ethnic differences in the
SULT1A1 genotypes incidence. Asian group differs from Caucasian and Tswana groups
because of its exceptionally high prevalence of individuals with the SULT1A1*1 genotype and a
very low incidence of the SULT1A1*2 genotype. The SULT1A1*1 genotype profiles of
Caucasian and Tswana groups were comparable, but notable differences were observed for the
SULT1A1*2 genotype.
Using a quantitative multiplex PCR method for the CNV study, the numbers of copies of the
SULT1A1 gene in the Tswana population were determined, and the results showed 1 to ~5
copies: only 0.65% of the subjects had a single copy, whereas 59.69% of the subjects had 3 or
more copies. This result shows a significant discrepancy between the Caucasian-American
samples, which showed that only 26% from that group had more than three copies. However,
there is a significant relationship with the African-American population, which presented 63%
with 3 or more copies. This finding confirms results from a much smaller African-American
study, and suggests a possible genetic link between the African Tswana and the heritage of the
African-Americans. These findings were submitted for publication to the South African Journal
of Science, as that journal specializes in publication of new knowledge that has a regional focus
on Africa. Simultaneous phenotypic consequences of the SNP and CNP of the SULT1A1 gene, as well as
the thermo-stable and thermo-labile forms of the sulfotransferases were determined. For this,
the formation of [35S]-4-nitrophenyl sulphate from 4-nitrophenol and [35S]-3’-phosphoadenosine-
5’-phosphosulfate ([35S]-PAPS) in platelet homogenates were measured, with the data
normalized to a common platelet count. This investigation required fresh blood for enzyme
activity. These samples came from 98 Caucasian subjects who voluntarily participated in this
part of the study. The experimental data presented a unique challenge to develop a statistical
model to accommodate the complexity of the distribution of the data in the phenotype and
genotype components, which could be achieved by the development of a mixed model. The
model indicated that product formation increased through increasing copy number, but did not
differ for SULT1A1*1 and SULT1A1*1/*2. However, the rate of increase in product for the
thermo-stable forms of the SULTs was greater than that of thermo-labile forms. In contrast, copy
number effect for SULT1A1*2 differed considerably from that of the other two genotypes. Since
genotype is also a significant factor, it was concluded from Tukey post-hoc tests that the
population group means for product formation differ significantly (for all levels). These results
are presently being prepared for publication in an accredited international journal.
Finally, perturbations in 23 biochemical parameters measured in the PURE study were
analyzed as a function of the SULT1A1 SNP and CNP were evaluated. No group separation in
this regard could be found. It could be shown however, that sulfonation of the iodothyronines,
which are endogenous substrates for the SULTs, was influenced by the SULT1A1 genotype.
The relative concentrations in plasma of the sulphonated iodothyronines may be expressed as
T2S > T3S >> T4S, which coincides with the substrate preference of the SULT1A1 enzymes.
This observation may, however, only be qualitatively interpreted as (1) the targeted
metabolomics mass spectrometric method used for the quantitative analysis of these
substances needs further development, and (2) the influence of deiodonation was not taken into
account in these studies. In conclusion, three perspectives are given at the end of the thesis
which might be considered for further investigations. / Thesis (Ph.D. (Biochemistry))--North-West University, Potchefstroom Campus, 2010.
|
22 |
Characterisation of the SULT1A1 polymorphism in a South African Tswana population group / y Hlengiwe P. Mbongwa.Mbongwa, Hlengiwe Prosperity January 2010 (has links)
This dissertation brings to the fore the “Characterization of the SULT1A1 polymorphism in a
South Africa Tswana population group.” The primary experimental group studied came from
South African homogeneous Tswana individuals who participated voluntarily in an ongoing
large-scale epidemiological Prospective Urban and Rural Epidemiological (PURE) study the
North-West University (Potchefstroom Campus) participates in, as one of the 16 low- middleand
high-income countries across the world.
The primary aspect investigated was the comprehensive profile of the single nucleotide
polymorphism (SNP) and copy number variation (CNP) of the SULT1A1 gene. Using the PCRbased
RFLP method, SULT1A1 genotypes, and allele frequency distributions in an
experimental group of 1 867 individuals were determined. According to the literature this is by
far the largest and most homogeneous group from which such information has been acquired to
date. The SULT1A1*1, SULT1A1*1/*2 and SULT1A1*2 genotypes were found to be present at
a percentage of 43.76, 47.12 and 9.11 respectively. In comparison to similar studies in other
population groups, results from this study indicate that there are ethnic differences in the
SULT1A1 genotypes incidence. Asian group differs from Caucasian and Tswana groups
because of its exceptionally high prevalence of individuals with the SULT1A1*1 genotype and a
very low incidence of the SULT1A1*2 genotype. The SULT1A1*1 genotype profiles of
Caucasian and Tswana groups were comparable, but notable differences were observed for the
SULT1A1*2 genotype.
Using a quantitative multiplex PCR method for the CNV study, the numbers of copies of the
SULT1A1 gene in the Tswana population were determined, and the results showed 1 to ~5
copies: only 0.65% of the subjects had a single copy, whereas 59.69% of the subjects had 3 or
more copies. This result shows a significant discrepancy between the Caucasian-American
samples, which showed that only 26% from that group had more than three copies. However,
there is a significant relationship with the African-American population, which presented 63%
with 3 or more copies. This finding confirms results from a much smaller African-American
study, and suggests a possible genetic link between the African Tswana and the heritage of the
African-Americans. These findings were submitted for publication to the South African Journal
of Science, as that journal specializes in publication of new knowledge that has a regional focus
on Africa. Simultaneous phenotypic consequences of the SNP and CNP of the SULT1A1 gene, as well as
the thermo-stable and thermo-labile forms of the sulfotransferases were determined. For this,
the formation of [35S]-4-nitrophenyl sulphate from 4-nitrophenol and [35S]-3’-phosphoadenosine-
5’-phosphosulfate ([35S]-PAPS) in platelet homogenates were measured, with the data
normalized to a common platelet count. This investigation required fresh blood for enzyme
activity. These samples came from 98 Caucasian subjects who voluntarily participated in this
part of the study. The experimental data presented a unique challenge to develop a statistical
model to accommodate the complexity of the distribution of the data in the phenotype and
genotype components, which could be achieved by the development of a mixed model. The
model indicated that product formation increased through increasing copy number, but did not
differ for SULT1A1*1 and SULT1A1*1/*2. However, the rate of increase in product for the
thermo-stable forms of the SULTs was greater than that of thermo-labile forms. In contrast, copy
number effect for SULT1A1*2 differed considerably from that of the other two genotypes. Since
genotype is also a significant factor, it was concluded from Tukey post-hoc tests that the
population group means for product formation differ significantly (for all levels). These results
are presently being prepared for publication in an accredited international journal.
Finally, perturbations in 23 biochemical parameters measured in the PURE study were
analyzed as a function of the SULT1A1 SNP and CNP were evaluated. No group separation in
this regard could be found. It could be shown however, that sulfonation of the iodothyronines,
which are endogenous substrates for the SULTs, was influenced by the SULT1A1 genotype.
The relative concentrations in plasma of the sulphonated iodothyronines may be expressed as
T2S > T3S >> T4S, which coincides with the substrate preference of the SULT1A1 enzymes.
This observation may, however, only be qualitatively interpreted as (1) the targeted
metabolomics mass spectrometric method used for the quantitative analysis of these
substances needs further development, and (2) the influence of deiodonation was not taken into
account in these studies. In conclusion, three perspectives are given at the end of the thesis
which might be considered for further investigations. / Thesis (Ph.D. (Biochemistry))--North-West University, Potchefstroom Campus, 2010.
|
23 |
Enzymové a metabolické přeměny silybinu a vybraných flavonoidů / Enzymatic and Metabolic Transformation of Silybin and its CongenersPurchartová, Kateřina January 2016 (has links)
Natural flavonoids and flavonolignans feature beneficial properties for living organisms such as antioxidant and hepatoprotective effects, anticancer, chemoprotective, dermatoprotective and hypocholesterolemic activities. Their metabolism in mammals is complex, the exact structure of their metabolites still remains partly unclear and the standards are usually not commercially available. Hence, this project focused on the preparation of potential and defined biotransformation Phase II sulfated metabolites of silymarin flavonolignans: silybin, 2,3-dehydrosilybin, isosilybin, silychristin, silydianin and flavonoids quercetin, taxifolin, rutin and isoquercitrin. Pure sulfated derivatives were prepared using aryl sulfotransferase from Desulfitobacterium hafniense and aryl sulfotransferase from rat liver. Using heterologously expressed PAPS (3'-phosphoadenosine-5'-phosophosulfate) - independent arylsulfotransferase from Desulfitobacterium hafniense and cheap p-nitrophenyl sulfate as sulfate donor, sulfated flavonolignans and flavonoids were obtained in high yields. Silymarin flavonolignans afforded exclusively monosulfates at the position C-20 (C-19 in the case of silychristin), except 2,3-dehydrosilybin that yielded also the 7,20-O-disulfated derivative. Isoquercitrin and rutin were selectively sulfated...
|
24 |
Konstruktion und Charakterisierung transgener Mauslinien für humane Sulfotransferasen als Modellsysteme für eine SULT-vermittelte metabolische Aktivierung / Construction and characterisation of transgenic mouse lines for human sulfotransferases as model systems for a SULT-mediated metabolic activationDobbernack, Gisela January 2008 (has links)
Die Enzyme der Sulfotransferase-Gensuperfamilie (SULT) konjugieren nukleophile Gruppen von kleinen endogenen Verbindungen und Fremdstoffen mit der negativ geladenen Sulfo-Gruppe. Dadurch wird die Polarität dieser Verbindungen erhöht, ihre passive Permeation von Zellmembranen verhindert und somit ihre Ausscheidung erleichtert. Jedoch stellt die Sulfo-Gruppe in bestimmten chemischen Verbindungen eine gute Abgangsgruppen dar. Aus der Spaltung resultierende Carbenium- oder Nitreniumionen können mit DNA oder anderen zellulären Nukleophilen reagieren. In Testsystemen für Mutagenität wurden zahlreiche Verbindungen, darunter Nahrungsinhaltsstoffe und Umweltkontaminanten, durch SULT zu Mutagenen aktiviert. Dabei zeigten sich zum einen eine ausgeprägte Substratspezifität selbst orthologer SULT-Formen unterschiedlicher Spezies und zum anderen Interspezies-Unterschiede in der SULT-Gewebeverteilung. Daher könnten sich die Zielgewebe einer SULT-induzierten Krebsentstehung bei Mensch und Nager unterscheiden.
Um die Beteiligung von humanen SULT an der Bioaktivierung von Fremdstoffen im Tiermodell untersuchen zu können, wurden transgene Mauslinien für den Cluster der humanen SULT1A1- und -1A2-Gene sowie für die humane SULT1B1 generiert. Zur Herstellung der transgenen Linien wurden große genomische Konstrukte verwendet, die die SULT-Gene sowie – zum Erreichen einer der Humansituation entsprechenden Gewebeverteilung der Proteinexpression – deren potentielle regulatorische Sequenzen enthielten.
Es wurden je drei transgene Linien für hSULT1A1/hSULT1A2 und drei transgene Linien für hSULT1B1 etabliert. Die Expression der humanen Proteine konnte in allen Linien gezeigt werden und fünf der sechs Linien konnten zur Homozygotie bezüglich der Transgene gezüchtet werden. In der molekularbiologischen Charakterisierung der transgenen Linien wurde der chromosomale Integrationsort der Konstrukte bestimmt und die Kopienzahl pro Genom untersucht. Mit Ausnahme einer hSULT1A1/hSULT1A2-transgenen Linie, bei der Kopien des Konstrukts in zwei unterschiedliche Chromosomen integriert vorliegen, wiesen alle Linien nur einen Transgen-Integrationsort auf. Die Untersuchung der Transgen-Kopienzahl ergab, dass die Mauslinien zwischen einer und etwa 20 Kopien des Transgen-Konstrukts pro Genom trugen. In der proteinbiochemischen Charakterisierung wurde gezeigt, dass die transgenen Linien die humanen Proteine mit einer weitgehend der des Menschen entsprechenden Gewebeverteilung exprimieren. Die Intensität der im Immunblot nachgewiesenen Expression korrelierte mit der Kopienzahl der Transgene. Die zelluläre und subzelluläre Verteilung der Transgen-Expression wurden bei einer der hSULT1A1/hSULT1A2-transgenen Linien in Leber, Niere, Lunge, Pankreas, Dünndarm und Kolon und bei einer der hSULT1B1-transgenen Linien im Kolon untersucht. Sie stimmte ebenfalls mit der Verteilung der entsprechenden SULT-Formen im Menschen überein.
Da sich die erzeugten transgenen Linien aufgrund ihrer mit dem Menschen vergleichbaren Gewebeverteilung der SULT-Expression als Modellsystem zur Untersuchung der menschlichen SULT-vermittelten metabolischen Aktivierung eigneten, wurde eine der hSULT1A1/hSULT1A2-transgenen Linien für zwei erste toxikologische Untersuchungen eingesetzt. Den Mäusen wurden chemische Verbindungen verabreicht, für die in in-vitro-Versuchen eine hSULT1A1/hSULT1A2-vermittelte Bioaktivierung zu Mutagenen gezeigt worden war. In beiden Untersuchungen wurde die Gewebeverteilung der entstandenen DNA-Addukte als Endpunkt einer gewebespezifischen genotoxischen Wirkung ermittelt. In der ersten Untersuchung wurden 90 mg/kg Körpergewicht 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridin – ein in gebratenem Fleisch gebildetes heterozyklisches aromatisches Amin – transgenen sowie Wildtyp-Mäusen oral verabreicht. Acht Stunden nach Applikation wiesen die transgenen Mäuse signifikant höhere Adduktniveaus als die Wildtyp-Mäuse in Leber, Lunge, Niere, Milz und Kolon auf. In der Leber der transgen Mäuse war das Adduktniveau 17fach höher als in der Leber der Wildtyp-Mäuse. Die Leber war bei den transgenen Tieren das Organ mit dem höchsten, bei den Wildtyp-Tieren hingegen mit dem niedrigsten DNA-Adduktniveau. In der zweiten Untersuchung (Pilotstudie mit geringer Tierzahl) wurde transgenen und Wildtyp-Mäusen 19 mg/kg Körpergewicht des polyzyklischen aromatischen Kohlenwasserstoffs 1-Hydroxymethylpyren – ein Metabolit der Nahrungs- und Umweltkontaminante 1-Methylpyren – intraperitoneal verabreicht. Nach 30 Minuten wurden, verglichen mit den Wildtyp-Mäusen, bis zu 25fach erhöhte Adduktniveaus bei den transgenen Mäusen in Leber, Niere, Lunge und Jejunum nachgewiesen. Somit konnte anhand einer in dieser Arbeit generierten transgenen Mauslinie erstmals gezeigt werden, dass die Expression der humanen SULT1A1/hSULT1A2 tatsächlich sowohl auf die Stärke als auch die Zielgewebe der DNA-Adduktbildung in vivo eine Auswirkung hat. / The enzymes of the sulfotransferase gene superfamily (SULT) conjugate nucleophilic groups of small endogenous compounds and xenobiotics with the negatively charged sulfo group. Thus, the polarity of the compounds is increased, their passive permeation of cell membranes is hindered and their excretion facilitated. The sulfate groups, however, form a good leaving group in certain chemical linkages due to their electron-withdrawing characteristics. Carbenium or nitrenium ions resulting from a spontaneous cleavage may react with DNA and other cellular nucleophiles. In test systems for mutagenicity, a large amount of compounds including ingredients of nutrition and environmental contaminants were activated to mutagens by SULT. A pronounced substrate specificity even of orthologous SULT forms of different species was evidenced. Also, the tissue distribution of SULT exhibited pronounced interspecies differences. The target tissues of a SULT induced carcinogenesis might thus be different in humans and rodents.
To investigate the involvement of human SULT in the bioactivation of xenobiotics in an animal model, transgenic mouse lines for the human SULT1A1- and -1A2 gene cluster as well as for human SULT1B1 were generated. For the construction of the transgenic lines, large genomic constructs were used, containing the SULT genes plus their potential regulatory sequences to cause a tissue distribution of protein expression corresponding to the situation in humans. Three transgenic lines for hSULT1A1/hSULT1A2 and three transgenic lines for hSULT1B1 were established. The expression of the human proteins could be shown for all lines and except for one line, all could be bred to transgene homozygosity. By molecular biological characterization of the transgenic lines, the chromosomal integration locus of the constructs was identified and the copy number per genome was investigated. With the exception of one hSULT1A1/hSULT1A2 transgenic line, where the construct had integrated into two different chromosomes, all lines exhibited just one transgene integration locus. By investigating the transgene copy number it was deduced that the mouse lines carry between one and 20 copies of the transgene construct per genome. The protein biochemical characterization showed that the transgenic mouse lines express the human proteins with a tissue distribution largely similar to the distribution in humans. The intensity of the proteins detected by immunoblotting correlated with the copy number of the transgenes. The cellular and subcellular distribution of the transgene expression was investigated for one of the hSULT1A1/1A2 transgenic lines in liver, kidney, lung, pancreas, small intestine and colon and for one of the hSULT1B1 transgenic lines in colon. It also accorded with the distribution of the respective SULT in humans.
Owing to the similarity of transgene expression to the corresponding human tissue distribution, the transgenic lines were considered suitable as model systems for the investigation of the human SULT-mediated metabolic activation. One of the hSULT1A1/hSULT1A2 transgenic lines was used in two first toxicological investigations with chemical compounds for which in vitro experiments had demonstrated a hSULT1A1/hSULT1A2 mediated bioactivation. In both investigations, the tissue distribution of the resulting DNA adducts was determined as an end point for a tissue-specific genotoxic effect. For the first investigation, 90 mg/kg bodyweight of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine – a heterocyclic amine formed in cooked meat – were orally administered to transgenic and wild type mice. Eight hours after application, the transgenic mice exhibited significantly higher adduct levels than the wild type controls in liver, lung, kidney, spleen and colon. The adduct level in the liver of the transgenic mice exceeded that in the wild type liver by a factor of 17. Furthermore, the liver was the organ with the highest adduct level in the transgenic mice and with the lowest adduct level in the wild type mice. For the second investigation (a pilot study with few animals), 19 mg/kg bodyweight of the polycyclic aromatic hydrocarbon 1-hydroxymethylpyrene – a metabolite of the nutritional and environmental contaminant 1-methylpyrene – were administered intraperitoneally to transgenic and wild type mice. After 30 minutes, up to 25 fold higher adduct levels compared to the wild type were detected in liver, kidney, lung and jejunum of the transgenic mice. Thus, by means of one of the transgenic mouse line generated in this thesis, it could be shown for the first time that the expression of human SULT1A1/SULT1A2 has in fact an impact on the strength as well as on the target tissue of DNA-adduct generation in vivo.
|
Page generated in 0.0606 seconds